Literature DB >> 22110232

Resection of solitary metachronous lymph node metastasis from hepatocellular carcinoma following transarterial chemotherapy with cisplatin: a case report.

Tomoharu Kurokawa1, Shintaro Yamazaki, Masamichi Moriguchi, Masaru Aoki, Yoshifumi Watanabe, Tokio Higaki, Tadatoshi Takayama.   

Abstract

A 74-year-old female was found to have a 40-mm liver tumor (in segment VIII) by ultrasonography and was diagnosed with hepatocellular carcinoma (HCC). She underwent liver resection and was stably treated without recurrence for 19 months. A 45-mm extrahepatic tumor was then found during follow-up with enhanced computed tomography and was diagnosed as being a metachronous lymph node (LN) metastasis. Angiography revealed that the metastasis LN was fed by both the right and left gastric arteries. Transarterial chemotherapy with cisplatin was scheduled to control LN metastasis and to prevent intrahepatic metastasis, simultaneously. Blood alteration using coil embolization was performed to isolate the feeding arteries before transarterial chemotherapy with cisplatin powder. The patient was stably treated for 6 months (3 times) and no new intra- or extrahepatic metastatic lesions appeared during the chemotherapy. The patient subsequently underwent systematic LN dissection of the porta hepatis. She was successfully treated, and has remained recurrence-free for almost 5 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22110232

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma.

Authors:  Michael L Caparelli; Nathan J Roberts; Timothy S Braverman; Robert M Stevens; Edward R Broun; Shyam Allamaneni
Journal:  World J Hepatol       Date:  2016-08-18

2.  Solitary Metastasis to a Distant Lymph Node in the Descending Mesocolon After Primary Resection for Hepatocellular Carcinoma: Is Surgical Resection Valid?

Authors:  Yuki Aisu; Hiroaki Furuyama; Tomohide Hori; Takafumi Machimoto; Toshiyuki Hata; Yoshio Kadokawa; Shigeru Kato; Yasuhisa Ando; Yuichiro Uchida; Daiki Yasukawa; Yusuke Kimura; Maho Sasaki; Yuichiro Takamatsu; Tunehiro Yoshimura
Journal:  Am J Case Rep       Date:  2016-12-01

3.  Complete remission by transarterial infusion with cisplatin for recurrent bile duct tumor thrombus of hepatocellular carcinoma: report of a case.

Authors:  Chiharu Ebara; Shintaro Yamazaki; Masamichi Moriguchi; Yusuke Mitsuka; Tomoya Funada; Tokio Higaki; Tadatoshi Takayama
Journal:  World J Surg Oncol       Date:  2013-03-23       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.